- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有23家主力机构披露2024-12-31报告期持股数据，持仓量总计1.23亿股，占流通A股42.92%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了85%的股票
技术面评分前10的股票
近期的平均成本为10.45元。
平均成本
近期的平均成本为10.45元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.45","date":1751430149,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.07.02","stock":"1.17","trade":"-1.00","ind":"-0.09"},{"date":"2025.07.01","stock":"1.89","trade":"3.49","ind":"0.39"},{"date":"2025.06.30","stock":"0.30","trade":"0.95","ind":"0.59"},{"date":"2025.06.27","stock":"0.20","trade":"0.71","ind":"-0.70"},{"date":"2025.06.26","stock":"-1.29","trade":"-1.17","ind":"-0.22"},{"date":"2025.06.25","stock":"-0.88","trade":"-0.56","ind":"1.03"},{"date":"2025.06.24","stock":"10.03","trade":"1.39","ind":"1.15"},{"date":"2025.06.23","stock":"0.98","trade":"1.63","ind":"0.65"},{"date":"2025.06.20","stock":"-0.11","trade":"0.13","ind":"-0.07"},{"date":"2025.06.19","stock":"-3.03","trade":"-2.75","ind":"-0.79"},{"date":"2025.06.18","stock":"-2.64","trade":"-1.39","ind":"0.04"},{"date":"2025.06.17","stock":"-1.21","trade":"-1.56","ind":"-0.04"},{"date":"2025.06.16","stock":"0.71","trade":"0.52","ind":"0.35"},{"date":"2025.06.13","stock":"-4.08","trade":"-2.47","ind":"-0.75"},{"date":"2025.06.12","stock":"1.38","trade":"1.34","ind":"0.01"},{"date":"2025.06.11","stock":"1.30","trade":"-0.36","ind":"0.52"},{"date":"2025.06.10","stock":"0.30","trade":"0.69","ind":"-0.44"},{"date":"2025.06.09","stock":"3.41","trade":"4.14","ind":"0.43"},{"date":"2025.06.06","stock":"0.00","trade":"0.45","ind":"0.04"},{"date":"2025.06.05","stock":"-1.53","trade":"-1.66","ind":"0.23"},{"date":"2025.06.04","stock":"0.51","trade":"0.41","ind":"0.42"}]
联环药业,上证指数,化学制药指数
压力支撑
该股压力位为10.37元，支撑位为10.07元。
[{"text":"\u538b\u529b\u4f4d","value":"10.37","date":1751385600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.07","date":1751385600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了3%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月03日 12:22
| 机构今日流向(万元) | -2961.84 | 机构5日流向(万元) | -2482.84 |
| 机构10日流向(万元) | -6697.08 | 机构20日流向(万元) | -19796.65 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少137.33万股，其中基金净增仓1家，主力净减仓9家，暂未发现中长期投资价值。
截止2024-12-31，共23家主力机构（基金19家，信托公司1家，一般法人2家，QFII1家），持仓量总计12253.03万股，占流通A股42.92%
其中，基金持仓与2024-06-30相比：
增仓：5家 ，增持 24.19万股
减仓：4家 ，减持 30.00万股
新出现在主力名单中：11家 ，持有111.74万股
从主力名单中消失：20家 ，原持有335.46万股
其中，基金持仓与2024-06-30相比：
增仓：5家 ，增持 24.19万股
减仓：4家 ，减持 30.00万股
新出现在主力名单中：11家 ，持有111.74万股
从主力名单中消失：20家 ，原持有335.46万股
消息面诊股
诊断结果：4.5消息面打败了1%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 联环药业加速美阿沙坦钾片商业化 创新转型步入收获期
2025-07-03 - 联环药业获1家机构调研：目前，公司在研创新药有6个
2025-07-02 - 联环药业亮相CPHI&PMEC China 202
2025-06-26 - 联环药业06月24日主力大幅流入
2025-06-24 - 创新药概念股拉升，联环药业涨停
2025-06-24 - 涨停雷达：创新药+一季报增长+国企改革 联环药业触
2025-06-24 - “救命药” 价暴涨百倍引公愤，合谋药企遭3.62亿
2025-06-20 - 联环药业：公司一类创新药LH-1801三期临床试验
2025-06-20 - 2025年中国日光性皮炎治疗行业产业链、重点企业分
2025-06-20 - 近两年业绩持续下滑 创新药项目融资遇阻 联环药业因
2025-06-18
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-06-11 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-05-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-05-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-10 |
| 一般消息 | 高管变动 | 因公司内部职务调整 | 2025-05-09 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-18 |
| 利好 | 分红转增 | 10派0.890元(含税) | 2025-04-18 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-18 |
| 一般消息 | 高管变动 | 委员会更名 | 2025-04-16 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-02-18 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2025-01-22 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2024-11-15 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-11-06 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.9行业面打败了82%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.07.02","price":"-0.09","value":"-1.00"},{"date":"2025.07.01","price":"0.39","value":"3.49"},{"date":"2025.06.30","price":"0.59","value":"0.95"},{"date":"2025.06.27","price":"-0.70","value":"0.71"},{"date":"2025.06.26","price":"-0.22","value":"-1.17"},{"date":"2025.06.25","price":"1.03","value":"-0.56"},{"date":"2025.06.24","price":"1.15","value":"1.39"},{"date":"2025.06.23","price":"0.65","value":"1.63"},{"date":"2025.06.20","price":"-0.07","value":"0.13"},{"date":"2025.06.19","price":"-0.79","value":"-2.75"},{"date":"2025.06.18","price":"0.04","value":"-1.39"},{"date":"2025.06.17","price":"-0.04","value":"-1.56"},{"date":"2025.06.16","price":"0.35","value":"0.52"},{"date":"2025.06.13","price":"-0.75","value":"-2.47"},{"date":"2025.06.12","price":"0.01","value":"1.34"},{"date":"2025.06.11","price":"0.52","value":"-0.36"},{"date":"2025.06.10","price":"-0.44","value":"0.69"},{"date":"2025.06.09","price":"0.43","value":"4.14"},{"date":"2025.06.06","price":"0.04","value":"0.45"},{"date":"2025.06.05","price":"0.23","value":"-1.66"},{"date":"2025.06.04","price":"0.42","value":"0.41"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 昂利康 | 166.63% | 36.68% | 5.9分 |
| 2 | 悦康药业 | 51.88% | 9.18% | 5.6分 |
| 3 | 美诺华 | 49.74% | 18.27% | 5.3分 |
| 4 | 永安药业 | 44.26% | 3.55% | 5.4分 |
| 5 | 易明医药 | 40.90% | -10.97% | 4.4分 |
| 6 | 舒泰神 | 32.61% | 20.16% | 6.1分 |
| 8 | 海辰药业 | 21.74% | -10.29% | 3.8分 |
| 10 | 北陆药业 | 19.88% | 6.94% | 5.5分 |
| 12 | 翰宇药业 | 18.18% | 6.00% | 5.3分 |
| 14 | 上海谊众 | 15.48% | 6.84% | 5.2分 |
| 16 | 诚意药业 | 13.10% | 15.21% | 5.7分 |
| 18 | 圣诺生物 | 12.04% | -2.64% | 5.4分 |
| 20 | 山河药辅 | 10.46% | 15.37% | 4.7分 |
| 22 | 亚太药业 | 8.91% | 2.36% | 5.2分 |
| 24 | 灵康药业 | 8.01% | 6.76% | 4.7分 |
| 26 | 益方生物 | 6.81% | -5.69% | 4.8分 |
| 28 | 联环药业 | 6.27% | 2.27% | 4.9分 |
| 30 | 诺泰生物 | 5.69% | -2.64% | 4.9分 |
| 32 | 北大医药 | 5.62% | 3.90% | 5.5分 |
| 34 | 共同药业 | 4.33% | 3.11% | 5.0分 |
| 36 | 纳微科技 | 3.78% | 5.76% | 5.9分 |
| 38 | 博瑞医药 | 3.67% | -3.57% | 3.7分 |
| 40 | 中关村 | 3.22% | 2.64% | 6.2分 |
| 42 | 福元医药 | 3.19% | 0.42% | 4.8分 |
| 44 | 能特科技 | 2.97% | 9.81% | 6.3分 |
| 46 | 宣泰医药 | 2.67% | 2.97% | 4.6分 |
| 48 | 本立科技 | 2.55% | 5.90% | 5.3分 |
| 50 | 亿帆医药 | 2.39% | 3.16% | 5.5分 |
| 52 | 东亚药业 | 1.63% | 2.75% | 4.9分 |
| 54 | 振东制药 | 1.32% | 3.36% | 5.5分 |
| 56 | 金陵药业 | 0.87% | 1.62% | 5.8分 |
| 58 | 海森药业 | 0.60% | 7.56% | 5.9分 |
| 60 | 汇宇制药 | 0.49% | -1.57% | 4.6分 |
| 62 | 莎普爱思 | 0.39% | 3.63% | 4.9分 |
| 64 | 福安药业 | 0.23% | 0.70% | 5.0分 |
| 66 | 广生堂 | 0.20% | 4.58% | 3.8分 |
| 68 | 吉贝尔 | 0.04% | -1.52% | 4.6分 |
| 70 | - | 0.00% | -0.29% | 分 |
| 72 | 国邦医药 | -0.35% | -0.30% | 5.1分 |
| 74 | 复旦张江 | -0.45% | 3.41% | 5.0分 |
| 76 | 科源制药 | -0.61% | 3.72% | 4.4分 |
| 78 | 西点药业 | -0.64% | 5.32% | 4.9分 |
| 80 | 浙江医药 | -0.86% | 3.33% | 5.0分 |
| 82 | 信立泰 | -0.93% | 2.94% | 5.1分 |
| 84 | 复星医药 | -1.06% | 1.04% | 4.8分 |
| 86 | 海创药业 | -1.13% | -1.81% | 3.8分 |
| 88 | - | -1.32% | 0.27% | 分 |
| 90 | 海欣股份 | -1.43% | 2.23% | 4.5分 |
| 92 | 尔康制药 | -1.50% | 4.13% | 5.0分 |
| 94 | 金城医药 | -1.69% | 7.38% | 6.1分 |
| 96 | 丽珠集团 | -1.85% | 1.38% | 5.5分 |
| 98 | 九典制药 | -2.00% | 4.05% | 4.4分 |
| 100 | 新和成 | -2.11% | -0.42% | 5.5分 |
| 102 | 百济神州 | -2.26% | -9.76% | 4.2分 |
| 104 | 拓新药业 | -2.78% | 2.94% | 3.6分 |
| 106 | 仙琚制药 | -2.94% | 0.22% | 5.1分 |
| 108 | 德展健康 | -3.25% | 2.19% | 5.0分 |
| 110 | 奥翔药业 | -3.56% | 2.17% | 5.0分 |
| 112 | 富祥药业 | -3.61% | 2.14% | 4.0分 |
| 114 | 向日葵 | -3.72% | 2.75% | 5.1分 |
| 116 | 百利天恒 | -4.15% | -2.00% | 3.9分 |
| 118 | 海普瑞 | -4.34% | 2.06% | 5.3分 |
| 120 | 健康元 | -4.72% | 0.63% | 4.5分 |
| 122 | 海思科 | -5.06% | 0.81% | 6.0分 |
| 124 | 哈三联 | -5.28% | 16.16% | 5.1分 |
| 126 | 多瑞医药 | -5.64% | -1.51% | 4.4分 |
| 128 | 京新药业 | -5.88% | -0.46% | 5.2分 |
| 130 | 溢多利 | -6.15% | 0.54% | 4.2分 |
| 132 | 汉商集团 | -6.28% | 4.22% | 5.4分 |
| 134 | 赛托生物 | -6.44% | -1.95% | 4.5分 |
| 136 | 人福医药 | -7.25% | -0.67% | 5.3分 |
| 138 | 兴齐眼药 | -7.75% | -0.12% | 4.4分 |
| 140 | 金石亚药 | -7.79% | 3.63% | 4.3分 |
| 142 | 立方制药 | -7.89% | 1.31% | 5.4分 |
| 144 | 华东医药 | -8.92% | -1.06% | 5.3分 |
| 146 | 恩华药业 | -10.35% | -1.64% | 5.3分 |
| 148 | 新天地 | -12.37% | 3.09% | 4.0分 |
| 150 | 河化股份 | -15.22% | 9.45% | 6.4分 |
| 152 | - | -23.69% | 0.00% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 67/227 ， 93/227。
[{"date":"2025-03-31","value":"1.64","vol":"-0.17"},{"date":"2024-12-31","value":"6.12","vol":"19.44"},{"date":"2024-09-30","value":"6.72","vol":"4.58"},{"date":"2024-06-30","value":"4.61","vol":"3.53"},{"date":"2024-03-31","value":"2.37","vol":"2.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.64 | 6.12 | 6.72 | 4.61 | 2.37 |
| 行业(%) | -0.17 | 19.44 | 4.58 | 3.53 | 2.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"41.50","vol":"49.23"},{"date":"2024-12-31","value":"49.37","vol":"51.10"},{"date":"2024-09-30","value":"49.89","vol":"50.51"},{"date":"2024-06-30","value":"50.97","vol":"50.84"},{"date":"2024-03-31","value":"49.14","vol":"50.75"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
41.50 | 49.37 | 49.89 | 50.97 | 49.14 |
| 行业(%) | 49.23 | 51.10 | 50.51 | 50.84 | 50.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/227 ， 98/227。
[{"date":"2025-03-31","value":"18.78","vol":"-0.86"},{"date":"2024-12-31","value":"-0.63","vol":"17.58"},{"date":"2024-09-30","value":"10.87","vol":"45.26"},{"date":"2024-06-30","value":"17.98","vol":"705.46"},{"date":"2024-03-31","value":"17.00","vol":"744.46"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
18.78 | -0.63 | 10.87 | 17.98 | 17.00 |
| 行业(%) | -0.86 | 17.58 | 45.26 | 705.46 | 744.46 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-29.15","vol":"-21.71"},{"date":"2024-12-31","value":"-37.66","vol":"-40.60"},{"date":"2024-09-30","value":"4.34","vol":"-0.63"},{"date":"2024-06-30","value":"2.21","vol":"8.83"},{"date":"2024-03-31","value":"4.58","vol":"18.72"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-29.15 | -37.66 | 4.34 | 2.21 | 4.58 |
| 行业(%) | -21.71 | -40.60 | -0.63 | 8.83 | 18.72 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 10/227 ， 44/227。
[{"date":"2025-03-31","value":"0.19","vol":"0.10"},{"date":"2024-12-31","value":"0.74","vol":"0.43"},{"date":"2024-09-30","value":"0.56","vol":"0.33"},{"date":"2024-06-30","value":"0.39","vol":"0.23"},{"date":"2024-03-31","value":"0.19","vol":"0.12"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.19 | 0.74 | 0.56 | 0.39 | 0.19 |
| 行业(次) | 0.10 | 0.43 | 0.33 | 0.23 | 0.12 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.72","vol":"0.67"},{"date":"2024-12-31","value":"2.90","vol":"3.23"},{"date":"2024-09-30","value":"2.39","vol":"2.17"},{"date":"2024-06-30","value":"1.60","vol":"1.51"},{"date":"2024-03-31","value":"0.88","vol":"0.74"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.72 | 2.90 | 2.39 | 1.60 | 0.88 |
| 行业(次) | 0.67 | 3.23 | 2.17 | 1.51 | 0.74 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-8.46","vol":"-28.86"},{"date":"2024-12-31","value":"-2.57","vol":"-368.97"},{"date":"2024-09-30","value":"9.94","vol":"-9.88"},{"date":"2024-06-30","value":"-1.60","vol":"-252.28"},{"date":"2024-03-31","value":"-3.38","vol":"-3.76"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -8.46 | -2.57 | 9.94 | -1.60 | -3.38 |
| 行业 | -28.86 | -368.97 | -9.88 | -252.28 | -3.76 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.98","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.79","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.98 | - | 3.79 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.19 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 62/227 ， 40/227。
[{"date":"2025-03-31","value":"1.17","vol":"3.59"},{"date":"2024-12-31","value":"1.10","vol":"3.32"},{"date":"2024-09-30","value":"0.97","vol":"3.67"},{"date":"2024-06-30","value":"0.99","vol":"3.60"},{"date":"2024-03-31","value":"1.10","vol":"3.71"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.17 | 1.10 | 0.97 | 0.99 | 1.10 |
| 行业 | 3.59 | 3.32 | 3.67 | 3.60 | 3.71 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.64","vol":"2.81"},{"date":"2024-12-31","value":"0.64","vol":"2.62"},{"date":"2024-09-30","value":"0.56","vol":"2.92"},{"date":"2024-06-30","value":"0.56","vol":"2.89"},{"date":"2024-03-31","value":"0.68","vol":"3.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.64 | 0.64 | 0.56 | 0.56 | 0.68 |
| 行业 | 2.81 | 2.62 | 2.92 | 2.89 | 3.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 5/227 ， 20/227。
[{"date":"2025-03-31","value":"50.71","vol":"33.96"},{"date":"2024-12-31","value":"47.77","vol":"34.28"},{"date":"2024-09-30","value":"47.92","vol":"32.89"},{"date":"2024-06-30","value":"47.28","vol":"33.06"},{"date":"2024-03-31","value":"45.08","vol":"32.53"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
50.71 | 47.77 | 47.92 | 47.28 | 45.08 |
| 行业(%) | 33.96 | 34.28 | 32.89 | 33.06 | 32.53 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.30","vol":"1.46"},{"date":"2024-12-31","value":"1.03","vol":"0.84"},{"date":"2024-09-30","value":"1.03","vol":"0.72"},{"date":"2024-06-30","value":"1.01","vol":"0.70"},{"date":"2024-03-31","value":"0.92","vol":"0.69"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.30 | 1.03 | 1.03 | 1.01 | 0.92 |
| 行业(%) | 1.46 | 0.84 | 0.72 | 0.70 | 0.69 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.35","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.84","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]